QUALITY OF LIFE IN END STAGE RENAL DISEASE PATIENTS

Author(s)

Kim J, Lee NR, Son SK, Sul AR, Kim YJ
National Evidence-based Collaborating Agency, Seoul, Korea, Republic of (South)

OBJECTIVES:  To evaluate health-related quality of life (HRQoL) in patients in vintages of end stage renal disease (ESRD). METHODS: The health states related with dialysis intervention was surveyed by face-to-face interview. We assessed HRQoL in terms of the state of health after dialysis. The HRQoL of 301 patients was measured mainly using EQ-5D. HRQoL was assessed using Korean version of the EQ-5D health questionnaire. We defined 3 vintages by treatment: Group 1: from diagnosis to 1year, Group 2: from 1 year to 5 year, Group 3: 5 year over. RESULTS: According to a study that analyzed a target of 154 peritoneal dialysis (PD) and 147 hemodialysis (HD) for the survey, the utility values are as follows. First, HRQoL showed that the mean value reduced greatly in patients who PD than HD. PD value is 0.86, HD value is 0.80. Second, the mean values were arranged in order from Group 1 to Group 3; PD Group 1 0.88, Group 2 0.87, Group 3 0.82; HD Group 1 0.82, Group 2 0.79, Group 3 0.80. CONCLUSIONS: The results shown that HRQoL has improved with peritoneal dialysis as compared to hemodialysis treatment. The treatment vintage has a negative impact on HRQol. HRQoL in end stage renal disease patients is an important outcome measure. Culture and disease specific QOL instruments that assess patients’ objective and subjective experiences covering most aspects of QOL are urgently needed.

Conference/Value in Health Info

2017-05, ISPOR 2017, Boston, MA, USA

Value in Health, Vol. 20, No. 5 (May 2017)

Code

PUK20

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities

Disease

Urinary/Kidney Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×